Cargando…
P-042: POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS ANALYSIS OF HYDROXYUREA, IN ADULT PATIENTS WITH SICKLE CELL DISEASE (SCD) RECEIVING BOTH TABLETS OR CAPSULES FORMULATIONS, AND EVALUATION OF DISEASE MARKERS
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429904/ http://dx.doi.org/10.1097/01.HS9.0000873064.94791.2e |
| _version_ | 1784779598219706368 |
|---|---|
| author | P., BARTOLUCCI S., LEZZAR A., HABIBI G., DE LUNA A., JEBALI S., MARTINO C., NOIZAT C., FAUROUX F., GALACTÉROS |
| author_facet | P., BARTOLUCCI S., LEZZAR A., HABIBI G., DE LUNA A., JEBALI S., MARTINO C., NOIZAT C., FAUROUX F., GALACTÉROS |
| author_sort | P., BARTOLUCCI |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429904 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94299042022-09-01 P-042: POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS ANALYSIS OF HYDROXYUREA, IN ADULT PATIENTS WITH SICKLE CELL DISEASE (SCD) RECEIVING BOTH TABLETS OR CAPSULES FORMULATIONS, AND EVALUATION OF DISEASE MARKERS P., BARTOLUCCI S., LEZZAR A., HABIBI G., DE LUNA A., JEBALI S., MARTINO C., NOIZAT C., FAUROUX F., GALACTÉROS Hemasphere Poster Presentations Lippincott Williams & Wilkins 2022-08-16 /pmc/articles/PMC9429904/ http://dx.doi.org/10.1097/01.HS9.0000873064.94791.2e Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Poster Presentations P., BARTOLUCCI S., LEZZAR A., HABIBI G., DE LUNA A., JEBALI S., MARTINO C., NOIZAT C., FAUROUX F., GALACTÉROS P-042: POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS ANALYSIS OF HYDROXYUREA, IN ADULT PATIENTS WITH SICKLE CELL DISEASE (SCD) RECEIVING BOTH TABLETS OR CAPSULES FORMULATIONS, AND EVALUATION OF DISEASE MARKERS |
| title | P-042: POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS ANALYSIS OF HYDROXYUREA, IN ADULT PATIENTS WITH SICKLE CELL DISEASE (SCD) RECEIVING BOTH TABLETS OR CAPSULES FORMULATIONS, AND EVALUATION OF DISEASE MARKERS |
| title_full | P-042: POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS ANALYSIS OF HYDROXYUREA, IN ADULT PATIENTS WITH SICKLE CELL DISEASE (SCD) RECEIVING BOTH TABLETS OR CAPSULES FORMULATIONS, AND EVALUATION OF DISEASE MARKERS |
| title_fullStr | P-042: POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS ANALYSIS OF HYDROXYUREA, IN ADULT PATIENTS WITH SICKLE CELL DISEASE (SCD) RECEIVING BOTH TABLETS OR CAPSULES FORMULATIONS, AND EVALUATION OF DISEASE MARKERS |
| title_full_unstemmed | P-042: POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS ANALYSIS OF HYDROXYUREA, IN ADULT PATIENTS WITH SICKLE CELL DISEASE (SCD) RECEIVING BOTH TABLETS OR CAPSULES FORMULATIONS, AND EVALUATION OF DISEASE MARKERS |
| title_short | P-042: POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS ANALYSIS OF HYDROXYUREA, IN ADULT PATIENTS WITH SICKLE CELL DISEASE (SCD) RECEIVING BOTH TABLETS OR CAPSULES FORMULATIONS, AND EVALUATION OF DISEASE MARKERS |
| title_sort | p-042: population pharmacokinetics and pharmacodynamics analysis of hydroxyurea, in adult patients with sickle cell disease (scd) receiving both tablets or capsules formulations, and evaluation of disease markers |
| topic | Poster Presentations |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429904/ http://dx.doi.org/10.1097/01.HS9.0000873064.94791.2e |
| work_keys_str_mv | AT pbartolucci p042populationpharmacokineticsandpharmacodynamicsanalysisofhydroxyureainadultpatientswithsicklecelldiseasescdreceivingbothtabletsorcapsulesformulationsandevaluationofdiseasemarkers AT slezzar p042populationpharmacokineticsandpharmacodynamicsanalysisofhydroxyureainadultpatientswithsicklecelldiseasescdreceivingbothtabletsorcapsulesformulationsandevaluationofdiseasemarkers AT ahabibi p042populationpharmacokineticsandpharmacodynamicsanalysisofhydroxyureainadultpatientswithsicklecelldiseasescdreceivingbothtabletsorcapsulesformulationsandevaluationofdiseasemarkers AT gdeluna p042populationpharmacokineticsandpharmacodynamicsanalysisofhydroxyureainadultpatientswithsicklecelldiseasescdreceivingbothtabletsorcapsulesformulationsandevaluationofdiseasemarkers AT ajebali p042populationpharmacokineticsandpharmacodynamicsanalysisofhydroxyureainadultpatientswithsicklecelldiseasescdreceivingbothtabletsorcapsulesformulationsandevaluationofdiseasemarkers AT smartino p042populationpharmacokineticsandpharmacodynamicsanalysisofhydroxyureainadultpatientswithsicklecelldiseasescdreceivingbothtabletsorcapsulesformulationsandevaluationofdiseasemarkers AT cnoizat p042populationpharmacokineticsandpharmacodynamicsanalysisofhydroxyureainadultpatientswithsicklecelldiseasescdreceivingbothtabletsorcapsulesformulationsandevaluationofdiseasemarkers AT cfauroux p042populationpharmacokineticsandpharmacodynamicsanalysisofhydroxyureainadultpatientswithsicklecelldiseasescdreceivingbothtabletsorcapsulesformulationsandevaluationofdiseasemarkers AT fgalacteros p042populationpharmacokineticsandpharmacodynamicsanalysisofhydroxyureainadultpatientswithsicklecelldiseasescdreceivingbothtabletsorcapsulesformulationsandevaluationofdiseasemarkers |